Antigen-Induced Release of Esterase (Protease) Activity from Rat Mast Cells as a Modulator of Type I Allergic Reaction?

1981 ◽  
Vol 66 (1) ◽  
pp. 159-164 ◽  
Author(s):  
O.-H. Wilhelms ◽  
E. Roesch
2019 ◽  
Vol 31 (4) ◽  
pp. 969-974
Author(s):  
Mire Spasov ◽  
Icko Gjorgoski

The allergic reaction or type I hypersensitivity is a hypersensitive disorder to the immune system, which occurs by ingress of non-pathogenic agents from the external environment in the body. Antigens, in this case allergens, are substances from the environment that are harmless to most people. In allergies there is an inherent tendency to inherit the genes that make these people susceptible to allergies. Rapid sensitization may occur as a local reaction, which is just unpleasant (seasonal rhinitis or hay fever), severe exhaustion (asthma), or culminating in a fatal systemic disorder (anaphylaxis). Allergens in the body are inserted by inhalation, ingestion or injection, and move to mucous membranes, where they are accepted by T-lymphocytes. TN2 lymphocytes produce IL-4, which stimulate B-lymphocytes to differentiate into plasma cells. These cells excrete IgE, which recognize allergens. Excreted IgE antibodies sensitize mast cells that originate from the bone marrow. When sensitized individuals again expose themselves to an allergen from the external environment, they bind to specific IgE-antibodies to the mast cells (memory cells), whereby various mediators are excreted, causing inflammatory response, mucus secretion, vasoconstriction of blood vessels, and spasm of the airways. The aim of the study was to investigate the allergenic effect of Daucus carotte on the change in the number of leukocytes, lymphocytes, monocytes, granulocytes, basophils, and immunoglobulins as important components of the immune system. From the pollen of this plant, recombinant allergen is extracted, in the form of injections with a volume of 150μI. In the experiments, as experimental models were used Wistar white rats at the age of 6 to 9 weeks. We injected the allergen into the first, second, third and fourth week in a group of 6 rats in an amount of 5 μl and a second group of 6 rats in an amount of 2.5 μl allergen absorbed in 100 μl AI (OH) 3 (Serva, Heidelburg, Germany, 2 μg / mI) in a total volume of 150μI sterile PbS. The third group of 6 rats was a control group. The results showed that the Dacus carota causes an allergic reaction in Wistar white rats and its intensity depends directly on the volume of the allergen and the individuals that come into contact with it. Once we compared the values of blood parameters, leukocytes, lymphocytes, monocytes, granulocytes, and basophils, as well as the IgG, IgG1, IgG2a, and IgE IgG, IgG1, IgG2a, and IgE concentrations, we concluded that the higher concentration of Daucus carota causes a higher elevation in blood parameters and concentrations of immunoglobulins, compared to the smaller concentration of the same allergen. From the studies conducted over a period of one month, it was found that Dacus carota causes an allergic reaction, which is classified in Type I hypersensitivity in white laboratory rats of the Wistar strain.


1991 ◽  
Vol 19 (03n04) ◽  
pp. 243-249 ◽  
Author(s):  
Tadayoshi Shibata ◽  
Takeshi Kono ◽  
Tsukasa Tanii ◽  
Nobuyuki Mizuno ◽  
Toshio Hamada

The effects of Ryo-kan-kyomi-sin-ge-nin-to (RKSG) extract, a medicinal agent traditionally used in China and Japan for treatment of asthma, on the degranulation of and histamine release from rat mast cells were studied. At a concentration of 5 mg/ml RKSG, degranulation of mast cells stimulated either by antigen (DNP-Ascaris) or compound 48/80 was markedly suppressed. At a concentration of 1-5 mg/ml RKSG, histamine release from mast cells due to application of either antigen or compound 48/80 was inhibited in a dose-dependent fashion. These results suggest that RKSG may be useful for the treatment of type I allergy-related diseases.


Ensho ◽  
1982 ◽  
Vol 2 (4) ◽  
pp. 339-340
Author(s):  
Toshiaki Nishigaki ◽  
Hidekazu Shigematsu

2019 ◽  
Vol 31 (4) ◽  
pp. 975-980
Author(s):  
Hristijan Spasov ◽  
Mire Spasov ◽  
Icko Gjorgoski ◽  
Majlinda Ademi

Allergic reactions in the body are initiated by non-pathogenic allergens that cause hypersensitivity to the immune system of the type I hypersensitivity group, characterized by excessive activation of the cells of the white blood cell, mast cells and basophils by IgE, resulting in an inflammatory response. The particles of the allergen in the body mainly penetrate the mucous membranes of the body openings causing a series of reactions by activating T cells and B cells. The main symptoms of allergic reactions are secretion from the mucous membrane, irritation, swelling with itching and redness. The aim of the research came from the assume that in the white laboratory rat, when treated with an allergen isolated from the pollen of the Phleum pratense plant, there may be an allergic reaction, and hence a change in some parameters of the immune system.As a result of these assumptions the following specific goals were set. To determine the change in the concentration of immunoglobulins in serum from the blood taken from the rats every week for a month, to determine the variation in the total number of leukocytes, determine the number of basophils that compared to the reference value will indicate whether there are certain changes. The basophils were the target of the study because it is known that their number is the same with the number of mast cells that also increase during the allergic reaction. Our goal was also to determine the changes in the above parameters in relation to the different concentration of the allergen.As an experimental model we used white laboratory rats from the Wistar kind.All of them were female at the age of 6 to 9 weeks. The chosen age is due to their genetic predisposition to develop Th2-type cells that are involved in the immune response to the model of the allergy that has been studied. The rats were divided into three groups of six animals, the first group of rats being treated with an allergen in a quantity of 5 μL, adsorbed in 100 μl Al (OH) 3 (Serva, Heidelburg, Germany, 2 mg / mL) in a total volume of 150 μl sterile PbS., treated with a recombinant allergen from Phleum pratense at room temperature, a second group treated with an allergen in an amount of 2.5 μl, and a third group of control rats that are not treated and serve to compare the results. Our studies have shown that in the treatment with an allergen isolated from the pollen of the plant Phleum pratense at concentrations of 5 μl and 2.5 μl,the white laboratory rat develops an allergic reaction with a change in the concentration of immunoglobulins, changes in the total number of leucocytes, the percentage of lymphocytes , monocytes and basophils. The results obtained by the ELISA test of the two volumes show that the concentrations of immunoglobulins during the experimental period of day by day, are continuously increasing, and are proportional to the volume of the allergen.


Cells ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1615
Author(s):  
Zhongwei Zhang ◽  
Yosuke Kurashima

It is well known that mast cells (MCs) initiate type I allergic reactions and inflammation in a quick response to the various stimulants, including—but not limited to—allergens, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs). MCs highly express receptors of these ligands and proteases (e.g., tryptase, chymase) and cytokines (TNF), and other granular components (e.g., histamine and serotonin) and aggravate the allergic reaction and inflammation. On the other hand, accumulated evidence has revealed that MCs also possess immune-regulatory functions, suppressing chronic inflammation and allergic reactions on some occasions. IL-2 and IL-10 released from MCs inhibit excessive immune responses. Recently, it has been revealed that allergen immunotherapy modulates the function of MCs from their allergic function to their regulatory function to suppress allergic reactions. This evidence suggests the possibility that manipulation of MCs functions will result in a novel approach to the treatment of various MCs-mediated diseases.


1976 ◽  
Vol 13 (4) ◽  
pp. 345-353 ◽  
Author(s):  
Wolfgang König ◽  
Kimishige Ishizaka
Keyword(s):  

1991 ◽  
Vol 111 (sup486) ◽  
pp. 162-175 ◽  
Author(s):  
Yoshihiro Ohashi ◽  
Yoshiaki Nakai ◽  
Yoshikazu Sugiura ◽  
Yoshiharu Ohno ◽  
Hideki Okamoto

Sign in / Sign up

Export Citation Format

Share Document